This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

Cefotaxime

Read time: 1 mins
Marketing start date: 27 Apr 2024

Summary of product characteristics


Effective Time

20230113

Version

5

Spl Product Data Elements

Cefotaxime cefotaxime injection CEFOTAXIME SODIUM CEFOTAXIME Cefotaxime cefotaxime injection CEFOTAXIME SODIUM CEFOTAXIME

Brand Name

Cefotaxime

Generic Name

cefotaxime injection

Product Ndc

21586-011

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAMUSCULAR,INTRAVENOUS

Package Label Principal Display Panel

Cefotaxime for Injection - 1 g per vial Sterile/Stérile DIN 02234091 cefoTAXime sodium for Injection BP 1 g per vial Cefotaxime sodium powder for solution Intramuscular or Intravenous Use Antibiotic/Antibiotique LATEX FREE/SANS LATEX STERIMAX 1gvial

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.